These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Mycobacterium abscessus resists the innate cellular response by surviving cell lysis of infected phagocytes. Touré H; Galindo LA; Lagune M; Glatigny S; Waterhouse RM; Guénal I; Herrmann JL; Girard-Misguich F; Szuplewski S PLoS Pathog; 2023 Mar; 19(3):e1011257. PubMed ID: 36972320 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Isogenic Strains Shows No Evidence of Altered Nosocomial Transmission-Competency of Rough, GPL-Negative Mycobacterium abscessus Strains. Meir M; Foreman M; Bar-Oz M; Naor N; Rozenblit A; Barkan D Microbiol Spectr; 2022 Apr; 10(2):e0199021. PubMed ID: 35311553 [TBL] [Abstract][Full Text] [Related]
31. Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D. Whang J; Back YW; Lee KI; Fujiwara N; Paik S; Choi CH; Park JK; Kim HJ Cell Death Dis; 2017 Aug; 8(8):e3012. PubMed ID: 28837151 [TBL] [Abstract][Full Text] [Related]
32. Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages. Kim SW; Subhadra B; Whang J; Back YW; Bae HS; Kim HJ; Choi CH Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 29044406 [TBL] [Abstract][Full Text] [Related]
33. MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection. Le Moigne V; Belon C; Goulard C; Accard G; Bernut A; Pitard B; Gaillard JL; Kremer L; Herrmann JL; Blanc-Potard AB Infect Immun; 2016 Oct; 84(10):2895-903. PubMed ID: 27481243 [TBL] [Abstract][Full Text] [Related]
34. MmpL8 Dubois V; Viljoen A; Laencina L; Le Moigne V; Bernut A; Dubar F; Blaise M; Gaillard JL; Guérardel Y; Kremer L; Herrmann JL; Girard-Misguich F Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10147-E10156. PubMed ID: 30301802 [No Abstract] [Full Text] [Related]
35. Glycopeptidolipid Genotype Correlates With the Severity of Mycobacterium abscessus Lung Disease. Li B; Ye M; Zhao L; Guo Q; Chen J; Xu B; Zhan M; Zhang Y; Zhang Z; Chu H J Infect Dis; 2020 Mar; 221(Suppl 2):S257-S262. PubMed ID: 32176786 [TBL] [Abstract][Full Text] [Related]
36. Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence. Nandanwar N; Gibson JE; Neely MN Microbiol Res; 2021 Dec; 253():126887. PubMed ID: 34628130 [TBL] [Abstract][Full Text] [Related]
37. Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients. Gutiérrez AV; Baron SA; Sardi FS; Saad J; Coltey B; Reynaud-Gaubert M; Drancourt M J Cyst Fibros; 2021 May; 20(3):421-423. PubMed ID: 33610476 [TBL] [Abstract][Full Text] [Related]
38. Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. Ripoll F; Deshayes C; Pasek S; Laval F; Beretti JL; Biet F; Risler JL; Daffé M; Etienne G; Gaillard JL; Reyrat JM BMC Genomics; 2007 May; 8():114. PubMed ID: 17490474 [TBL] [Abstract][Full Text] [Related]
39. Colony morphotype governs innate and adaptive pulmonary immune responses to Mycobacterium abscessus infection in C3HeB/FeJ mice. Ferrell KC; Stewart EL; Counoupas C; Triccas JA Eur J Immunol; 2024 Jul; 54(7):e2350610. PubMed ID: 38576227 [TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. van Ingen J; de Zwaan R; Dekhuijzen RP; Boeree MJ; van Soolingen D J Infect; 2009 Nov; 59(5):324-31. PubMed ID: 19732795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]